The clinical study for Dasatinib and Homoharringtonine in treating core binding factor acute myeloid leukemia
Latest Information Update: 03 Oct 2019
At a glance
- Drugs Dasatinib (Primary) ; Omacetaxine mepesuccinate (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
Most Recent Events
- 03 Oct 2019 New trial record